CBCole Bortz

Cole Bortz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cole Bortz has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Prevalence of Hip Pathologies in Adolescent Idiopathic Scoliosis

    by Cole Bortz, Tyler K. Williamson, Ammar Adenwalla, Sara Naessig, Bailey Imbo, Lara Passfall, Oscar Krol, Peter Tretiakov, Rachel Joujon-Roche, Kevin Moattari, et al.


  • A predictive model of perioperative myocardial infarction following elective spine surgery

    by Peter G Passias, Katherine E Pierce, Haddy Alas, Cole Bortz, Avery E Brown, Dennis Vasquez-Montes, Cheongeun Oh, Erik Wang, Deeptee Jain, Brooke K O'Connell, et al.


  • Predictors of serious, preventable, and costly medical complications in a population of adult spinal deformity patients

    by Haddy Alas, Peter G. Passias, Avery E. Brown, Katherine E. Pierce, Cole Bortz, Shay Bess, Renaud Lafage, Virginie Lafage, Christopher P. Ames, Douglas C. Burton, et al.


  • Predictors of Superior Recovery Kinetics in Adult Cervical Deformity Correction

    by Katherine E. Pierce, Peter G. Passias, Avery E. Brown, Cole A. Bortz, Haddy Alas, Renaud Lafage, Virginie Lafage, Christopher Ames, Douglas C Burton, Robert Hart, et al.

    Study Design.: Retrospective review of a prospective database. Objective.: The aim of this study was to identify demographic, surgical, and radiographic factors that predict superior recovery kinetics following cervical deformity (CD) corrective surgery. Summary of Background Data.: Analyses of CD corrective surgery use area under the curve (AUC) to assess health-related quality of life (HRQL) metrics throughout recovery. Methods.: Outcome measures were baseline (BL) to 1-year (1Y) health-related quality of life (HRQL) (Neck Disability Index [NDI]). CD criteria were C2-7 Cobb angle >10°, coronal Cobb angle >10°, C2-C7 sagittal vertical axis (cSVA) >4 cm, TS-CL >10°, or chin-brow vertical angle >25°. AUC normalization divided BL and postoperative outcomes by BL. Normalized scores (y axis) were plotted against follow-up (x axis). AUC was calculated and divided by cumulative follow-up length to determine overall, time-adjusted recovery (Integrated Health State [IHS]). IHS NDI was stratified by quartile, uppermost 25% being “Superior" Recovery Kinetics (SRK) versus “Normal" Recovery Kinetics (NRK). BL demographic, clinical, and surgical information predicted SRK using generalized linear modeling. Results.: Ninety-eight patients included (62 ± 10 years, 28 ± 6 kg/m2, 65% females, Charlson Comorbidity Index: 0.95), 6% smokers, 31% smoking history. Surgical approach was: combined (33%), posterior (49%), anterior (18%). Posterior levels fused: 8.7, anterior: 3.6, estimated blood loss: 915.9ccs, operative time: 495 minutes. Ames BL classification: cSVA (53.2% minor deformity, 46.8% moderate), TS-CL (9.8% minor, 4.3% moderate, 85.9% marked), horizontal gaze (27.4% minor, 46.6% moderate, 26% marked). Relative to BL NDI (Mean: 47), normalized NDI decreased at 3 months (0.9 ± 0.5, P = 0.260) and 1Y (0.78 ± 0.41, P < 0.001). NDI IHS correlated with age (P = 0.011), sex (P = 0.042), anterior approach (P = 0.042), posterior approach (P = 0.042). Greater BL pelvic tilt (PT) (SRK: 25.6°, NRK: 17°, P = 0.002), pelvic incidence-lumbar lordosis (PI-LL) (SRK: 8.4°, NRK: −2.8°, P = 0.009), and anterior approach (SRK: 34.8%, NRK: 13.3%; P = 0.020) correlated with SRK. 69.4% met MCID for NDI (<Δ–15) and 63.3% met substantial clinical benefit for NDI (<Δ–10); 100% of SRK met both MCID and substantial clinical benefit. The predictive model for SRK included (AUC = 88.1%): BL visual analog scale (VAS) EuroQol five-dimensional descriptive system (EQ5D) (odds rario [OR] 0.96, 95% confidence interval [CI]: 0.92–0.99), BL swallow sleep score (OR: 1.04, 95% CI: 1.01–1.06), BL PT (OR: 1.12, 95% CI: 1.03–1.22), BL modified Japanese Orthopedic Association scale (mJOA) (OR: 1.5, 95% CI: 1.07–2.16), BL T4-T12, BL T10-L2, BL T12-S1, and BL L1-S1. Conclusion.: Superior recovery kinetics following CD surgery was predicted with high accuracy using BL patient-reported (VAS EQ5D, swallow sleep, mJOA) and radiographic factors (PT, TK, T10-L2, T12-S1, L1-S1). Awareness of these factors can improve decision-making and reduce postoperative neck disability. Level of Evidence: 3


  • Does Matching Roussouly Spinal Shape and Improvement in SRS-Schwab Modifier Contribute to Improved Patient-reported Outcomes?

    by Peter G. Passias, Katherine E. Bs Pierce, Tina Raman, Cole Ba Bortz, Haddy Bs Alas, Avery Bs Brown, Waleed Ahmad, Sara Bs Naessig, Oscar Ba Krol, Lara Bs Passfall, et al.

    Study Design.: Retrospective review. Objective.: The aim of this study was to evaluate outcomes of matching Roussouly and improving in Schwab modifier following adult spinal deformity (ASD) surgery. Summary of Background Data.: The Roussouly Classification system of sagittal spinal shape and the SRS-Schwab classification system have become important indicators of spine deformity. No previous studies have examined the outcomes of matching both Roussouly type and improving in Schwab modifiers postoperatively. Methods.: Surgical ASD patients with available baseline (BL) and 1 year (1Y) radiographic data were isolated in the single-center spine database. Patients were classified by their “theoretical” and “current” Roussouly types as previously published. Patients were considered a “Match” if their theoretical and current Roussouly types were the same, or a “Mismatch” if the types differed. Patients were noted as improved if they were Roussouly “Mismatch” preoperatively, and “Match” at 1Y postop. Schwab modifiers at BL were categorized as follows: no deformity (0), moderate deformity (+), and severe deformity (++) for PT, SVA, and PI-LL. Improvement in SRS-Schwab was defined as a decrease in any modifier severity at 1Y. Results.: 103 operative ASD patients (61.8 years, 63.1% female, 30 kg/m2) were included. At baseline, breakdown of “current” Roussouly type was: 28% Type 1, 25.3% Type 2, 32.0% Type 3, 14.7% Type 4. 65.3% of patients were classified as Roussouly “Mismatch” at BL. Breakdown of BL Schwab modifier severity: PT (+: 41.7%, ++: 49.5%), SVA (+: 20.3%, ++: 50%), PI-LL (+: 25.2%, ++: 46.6%). At 1 year postop, 19.2% of patients had Roussouly “Match”. Analysis of Schwab modifiers showed that 12.6% improved in SVA, 42.7% in PI-LL, and 45.6% in PT. Count of patients who both had a Roussouly type “Match” at 1Y and improved in Schwab modifier severity: nine PT (8.7%), eight PI-LL (7.8%), and two SVA (1.9%). There were two patients (1.9%) who met their Roussouly type and improved in all three Schwab. 1Y matched Roussouly patients improved more in health-related quality of life scores (minimal clinically important difference [MCID] for Oswestry Disability Index [ODI], EuroQol-5D-3L [EQ5D], Visual Analogue Score Leg/Back Pain), compared to mismatched, but was not significant (P > 0.05). Match Roussouly and improvement in PT Schwab met MCID for EQ5D more (P = 0.050). Matched Roussouly and improvement in SVA Schwab met MCID for ODI more (P = 0.024). Conclusion.: Patients who both matched Roussouly sagittal spinal type and improved in SRS-Schwab modifiers had superior patient-reported outcomes. Utilizing both classification systems in surgical decision-making can optimize postop outcomes. Level of Evidence: 3


  • A cost utility analysis of treating different adult spinal deformity frailty states

    by Avery E. Brown, Jordan Lebovic, Haddy Alas, Katherine E. Pierce, Cole A. Bortz, Waleed Ahmad, Sara Naessig, Hamid Hassanzadeh, Lawal A. Labaran, Varun Puvanesarajah, et al.


  • P74. Adult spinal deformity patients with metabolic syndrome have significantly higher costs

    by Peter G. Passias, Avery Brown, Katherine E. Pierce, Cole Bortz, Haddy Alas, Hamid Hassanzadeh, Lawal Labaran, Themistocles S. Protopsaltis, Aaron J. Buckland


  • Readmission in elective spine surgery: Will short stays be beneficial to patients

    by Avery E. Brown, Hesham Saleh, Sara Naessig, Katherine E. Pierce, Waleed Ahmad, Cole A. Bortz, Haddy Alas, Irene Chern, Dennis Vasquez-Montes, Rivka C. Ihejirika, et al.


  • Epidural Steroid Injections for Management of Degenerative Spondylolisthesis

    by Michael C. Gerling, Cole Bortz, Katherine E. Pierce, Jon D. Lurie, Wenyan Zhao, Peter G. Passias

    Background: Although epidural steroid injection (ESI) may provide pain relief for patients with degenerative spondylolisthesis in treatment regimens of up to 4 months, it remains unclear whether ESI affects crossover from nonoperative to operative management. Methods: This retrospective cohort study analyzed 2 groups of surgical candidates with degenerative spondylolisthesis: those who received ESI within 3 months after enrollment (ESI group) and those who did not (no-ESI group). Annual outcomes following enrollment were assessed within operative and nonoperative groups (patients who initially chose or were assigned to surgery or nonoperative treatment) by using longitudinal mixed-effect models with a random subject intercept term accounting for correlations between repeated measurements. Treatment comparisons were performed at follow-up intervals. Area-under-the-curve analysis for all time points assessed the global significance of treatment. Results: The study included 192 patients in the no-ESI group and 74 in the ESI group. The no-ESI group had greater baseline Short Form-36 (SF-36) Bodily Pain scores (median, 35 versus 32) and self-reported preference for surgery (38% versus 11%). There were no differences in surgical rates within 4 years after enrollment between the no-ESI and ESI groups (61% versus 62%). The surgical ESI and no-ESI groups also showed no differences in changes in patient-reported outcomes at any follow-up interval or in the 4-year average. Compared with the nonoperative ESI group, the nonoperative no-ESI group showed greater improvements in SF-36 scores for Bodily Pain (p = 0.004) and Physical Function (p = 0.005) at 4 years, Bodily Pain at 1 year (p = 0.002) and 3 years (p = 0.005), and Physical Function at 1 year (p = 0.030) and 2 years (p = 0.002). Of the patients who were initially treated nonsurgically, those who received ESI and those who did not receive ESI did not differ with regard to surgical crossover rates. The rates of crossover to nonoperative treatment by patients who initially chose or were assigned to surgery also did not differ between the ESI and no-ESI groups. Conclusions: There was no relationship between ESI and improved clinical outcomes over a 4-year study period for patients who chose or were assigned to receive surgery for degenerative spondylolisthesis. In the nonsurgical group, ESI was associated with inferior pain reduction through 3 years, although this was confounded by greater baseline pain. ESI showed little relationship with surgical crossover. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Comparative outcomes of operative relative to medical management of spondylodiscitis accounting for frailty status at presentation

    by Haddy Alas, Hasanga Fernando, Joseph F. Baker, Avery E Brown, Cole Bortz, Sara Naessig, Katherine E Pierce, Waleed Ahmad, Bassel G. Diebo, Peter G Passias